Skip to content
Dose Brief
Menu
Independent GLP-1 newsroomUpdated June 30, 2026

The 5-minute GLP-1 briefing — prices, shortages, and provider moves.

A plain-English desk tracking what GLP-1 telehealth actually costs this week, what's in supply, and which providers earn our six-factor Brief Score. 9 providers on the board. No pay-to-win placement.

● The Dose Brief newsletter

One brief. Five minutes. Every price move in your inbox.

We read the GLP-1 market so you don't have to — flat-rate holds, teaser-tier resets, shortage flips, and provider changes, distilled into a short weekly brief.

Subscribe free

Join readers who get the GLP-1 briefing before they pick a provider.

Free. One 5-minute brief. Unsubscribe anytime.

Latest briefs

Newest first

This week in GLP-1

The price tracker

Headline monthly compounded prices at our tracked desks, with the direction each moved since our last check. A falling line is good news for you; rising is worth a second look.

ProviderSemaglutideTirzepatideTrend
CoreAge RxPartner$149/mo$349/moStableprice stable
EdenPartner$239/mo$349/moStableprice stable
Invigor MedicalPartner$199/mo$339/moStableprice stable
ShedRxPartner$199/mo$299/moFallingprice falling
AgelessRxPartner$139/moNot disclosedStableprice stable
RoNot disclosedNot disclosedStableprice stable
Found$129/mo$129/moStableprice stable
Hims & Hers$199/moNot disclosedRisingprice rising
Henry Meds$249/mo$349/moRisingprice rising

Prices reflect each desk's public disclosures at last check (June 30, 2026) and change often — confirm on the provider's own site. Not medical advice.

Shortage status

Semaglutide (brand)In supply

Off the FDA shortage list; brand supply resolved.

Tirzepatide (brand)In supply

Off the FDA shortage list since late 2024.

Compounded supplyWatch

Legal but under ongoing FDA scrutiny — sourcing matters.

The board

Best GLP-1 providers, by Brief Score

Scored on six factors: price stability · supply reliability · transparency · access breadth · clinical oversight · track record.

Lead story · #1 on the board
No. 1Grade A

CoreAge Rx

Partner

The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Semaglutide
$149/mo
Tirzepatide
$349/mo
Coverage
All 50 states
Price trend
Stableprice stable
  • Flat monthly price with no intro-rate step-up after month one — the most stable line on our tracker
  • Both compounded semaglutide and tirzepatide on one account
  • Available in all 50 states — the widest reliable footprint in the partner tier
  • Not the rock-bottom price — cheaper teaser tiers exist, but they don't hold
  • No FDA-approved brand-name option (compounded only)
  • Does not yet publicly name its 503A/B pharmacy partner
Visit CoreAge Rx Read the full brief →
No. 2Grade A−

Eden

Partner

A polished, high-disclosure program with strong nationwide coverage — you pay more, but you know exactly what you're paying for.

Semaglutide
$239/mo
Tirzepatide
$349/mo
Coverage
All 50 states
Price trend
Stableprice stable
  • High verification confidence — clear supply-chain and clinician disclosure
  • Nationwide availability
  • Both molecules offered at a stable published rate
  • Premium pricing vs the cheapest tiers
  • Compounded only — no brand-name access
Visit Eden Read the full brief →
No. 3Grade B+

Invigor Medical

Partner

An established telehealth pharmacy with a broad metabolic and hormone catalog and a steady price line.

Semaglutide
$199/mo
Tirzepatide
$339/mo
Coverage
Not disclosed
Price trend
Stableprice stable
  • Mid-market pricing on both molecules, held steady
  • Long-running operator with a deep track record
  • Broad catalog beyond GLP-1
  • Does not publish an explicit states-served list
  • Compounded only
Visit Invigor Medical Read the full brief →
No. 4Grade B+

ShedRx

Partner

A weight-focused program with the lowest tracked tirzepatide rate and an oral/sublingual route for the needle-averse.

Semaglutide
$199/mo
Tirzepatide
$299/mo
Coverage
Not disclosed
Price trend
Fallingprice falling
  • Offers oral/sublingual forms — wider formulary than most
  • Lowest tracked tirzepatide price
  • Competitive on both molecules
  • States-served not disclosed
  • Compounded only
Visit ShedRx Read the full brief →
No. 5Grade B

AgelessRx

Partner

A longevity-leaning brand with the lowest tracked semaglutide sticker — but a thin disclosure on the rest.

Semaglutide
$139/mo
Tirzepatide
Not disclosed
Coverage
Not disclosed
Price trend
Stableprice stable
  • Lowest tracked semaglutide price
  • Offers some brand-name access
  • Established longevity brand
  • Tirzepatide pricing not disclosed
  • States-served not disclosed
Visit AgelessRx Read the full brief →
No. 6Grade B+

Ro

Editorial review

A heavyweight platform with brand-name access and a polished experience — but it keeps compounded pricing off the record.

Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Multi-state
Price trend
Stableprice stable
  • Brand-name (Wegovy/Zepbound) access and insurance support
  • Oral options
  • Well-funded, reliable platform
  • Does not publicly disclose compounded pricing up front
  • Premium positioning
Visit Ro Read the full brief →
No. 7Grade B+

Found

Editorial review

A coaching-first program with the lowest identical price on both molecules — if you want the coaching lock-in that comes with it.

Semaglutide
$129/mo
Tirzepatide
$129/mo
Coverage
All 50 states
Price trend
Stableprice stable
  • Low, identical pricing on both molecules
  • Nationwide
  • Strong behavior-change program
  • Coaching subscription model isn't for everyone
  • Compounded only
Visit Found Read the full brief →
No. 8Grade B

Hims & Hers

Editorial review

Mass-market, app-first weight program with nationwide reach — watch the compounded-supply headlines.

Semaglutide
$199/mo
Tirzepatide
Not disclosed
Coverage
All 50 states
Price trend
Risingprice rising
  • Nationwide
  • Slick app experience
  • Strong brand trust
  • Tirzepatide pricing not consistently disclosed
  • Compounded supply has drawn regulatory scrutiny industry-wide
Visit Hims & Hers Read the full brief →
No. 9Grade B

Henry Meds

Editorial review

A flat-fee compounded pioneer — simple model, but its price has drifted to the higher end of our board.

Semaglutide
$249/mo
Tirzepatide
$349/mo
Coverage
Multi-state
Price trend
Risingprice rising
  • Simple flat-fee model
  • Well-established brand
  • Both molecules
  • Higher pricing than many newer entrants
  • Compounded only
Visit Henry Meds Read the full brief →

Partner = available through our affiliate program; editorial review = no commercial relationship. Prices, states and verification reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on the provider's site. See our disclosure. Not medical advice.